The mast cell in innate and adaptive immunity.

Published

Journal Article (Review)

Mast cells (MCs) were once considered only as effector cells in pathogenic IgE- and IgG-mediated responses such as allergy. However, developments over the last 15 years have suggested that MCs have evolved in vertebrates as beneficial effector cells that are involved in the very first inflammatory responses generated during infection. This pro-inflammatory environment has been demonstrated to be important for initiating innate responses in many different models of infection and more recently, in the development of adaptive immunity as well. Interestingly this latter finding has led to the discovery that small MC-activating compounds can behave as adjuvants in vaccine formulations. Thus, our continued understanding of the MC in the context of infectious disease is likely to not only expand our scope of the MC in the normal processes of immunity, but provide new therapeutic targets to combat disease.

Full Text

Duke Authors

Cited Authors

  • Shelburne, CP; Abraham, SN

Published Date

  • 2011

Published In

Volume / Issue

  • 716 /

Start / End Page

  • 162 - 185

PubMed ID

  • 21713657

Pubmed Central ID

  • 21713657

International Standard Serial Number (ISSN)

  • 0065-2598

Digital Object Identifier (DOI)

  • 10.1007/978-1-4419-9533-9_10

Language

  • eng

Conference Location

  • United States